These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25688079)

  • 1. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
    Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
    Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease.
    Dorr A; Sahota B; Chinta LV; Brown ME; Lai AY; Ma K; Hawkes CA; McLaurin J; Stefanovic B
    Brain; 2012 Oct; 135(Pt 10):3039-50. PubMed ID: 23065792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models.
    Thomason LA; Stefanovic B; McLaurin J
    Eur J Neurosci; 2013 Jun; 37(12):1994-2004. PubMed ID: 23773069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venular amyloid accumulation in transgenic Fischer 344 Alzheimer's disease rats.
    Bishay J; Beckett TL; Lai AY; Hill ME; McMahon D; McLaurin J
    Sci Rep; 2022 Sep; 12(1):15287. PubMed ID: 36088484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
    Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
    Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6 T.
    Kara F; Dongen ES; Schliebs R; Buchem MA; Groot HJ; Alia A
    Neuroimage; 2012 Apr; 60(2):958-66. PubMed ID: 22227054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.
    Joo IL; Lai AY; Bazzigaluppi P; Koletar MM; Dorr A; Brown ME; Thomason LA; Sled JG; McLaurin J; Stefanovic B
    Sci Rep; 2017 Apr; 7():46427. PubMed ID: 28401931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of sensory-evoked hemodynamic response in an early Alzheimer's disease mouse model.
    Kim J; Jeong Y
    J Alzheimers Dis; 2013; 37(4):857-68. PubMed ID: 23948921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
    Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
    Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
    Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
    Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
    Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
    Castellani RJ; Smith MA; Perry G; Friedland RP
    Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue.
    Zedde M; Grisendi I; Assenza F; Vandelli G; Napoli M; Moratti C; Lochner P; Seiffge DJ; Piazza F; Valzania F; Pascarella R
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
    Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
    J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of Alzheimer's disease cause rarefaction of pial collaterals and increased severity of ischemic stroke.
    Zhang H; Jin B; Faber JE
    Angiogenesis; 2019 May; 22(2):263-279. PubMed ID: 30519973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis.
    Princz-Kranz FL; Mueggler T; Knobloch M; Nitsch RM; Rudin M
    Neurobiol Dis; 2010 Oct; 40(1):284-92. PubMed ID: 20600914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-resolution ultrasound imaging reveals temporal cerebrovascular changes with disease progression in female 5×FAD mouse model of Alzheimer's disease: correlation with pathological impairments.
    Lin H; Wang Z; Liao Y; Yu Z; Xu H; Qin T; Tang J; Yang X; Chen S; Chen X; Zhang X; Shen Y
    EBioMedicine; 2024 Oct; 108():105355. PubMed ID: 39293213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.